Article
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.
Blood - 7 May 2009
Gaidzik Verena Ingeborg, Schlenk Richard Friedrich, Moschny Simone, Becker Annegret, Bullinger Lars, Corbacioglu Andrea, Krauter Jürgen, Schlegelberger Brigitte, Ganser Arnold, Döhner Hartmut, Döhner Konstanze
Abstract excerpt
To evaluate the incidence and clinical impact of WT1 gene mutations in younger adult patients with cytogenetically normal acute myeloid leukemia (CN-AML), sequencing of the complete coding region was performed in diagnostic samples from 617 patients who were treated on 3 German-Austrian AML Study Group protocols. WT1 mutations were identified in 78 (12.6%) of the 617 patients; mutations clustered in exon 7 (54 of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
